CA
BBH icon

CoreCap Advisors’s VanEck Biotech ETF BBH Stock Holding History

CoreCap Advisors’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.6K Hold
190
– – ﹤0.01% 1515
2026
Q1 		$35.7K Hold
190
– – ﹤0.01% 1453
2025
Q4 		$36K Hold
190
– – ﹤0.01% 1460
2025
Q3 		$31.5K Hold
190
– – ﹤0.01% 1499
2025
Q2 		$29.1K Hold
190
– – ﹤0.01% 1470
2025
Q1 		$29.9K Hold
190
– – ﹤0.01% 1379
2024
Q4 		$29.8K Hold
190
– – ﹤0.01% 1393
2024
Q3 		$33.7K Hold
190
– – ﹤0.01% 1348
2024
Q2 		$32K Hold
190
– – ﹤0.01% 768
2024
Q1 		$31.6K Buy
+190
New +$31.5K ﹤0.01% 1289
2022
Q3 		– Sell
-3
Closed – – 667
2022
Q2 		$0 Buy
+3
New +$447 ﹤0.01% 2127
2022
Q1 		– Sell
-26
Closed -$5K – 678
2021
Q4 		$5K Buy
+26
New +$5.01K ﹤0.01% 1739

Other funds holding BBH

HFAS
Hummer Financial Advisory Services Chicago, Illinois $152M AUM 20.1% 1-Year Est. Return
VIP
Value Investment Professionals New York $119M AUM
PAW
Plan A Wealth Lincoln, Nebraska $235M AUM 22.68% 1-Year Est. Return
FFN
Focus Financial Network Minneapolis, Minnesota $3.23B AUM 29.61% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
PP
Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return

CoreCap Advisors's BBH Position: Q2 2026 in Review

CoreCap Advisors held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 190 shares worth $38.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

CoreCap Advisors first reported a position in BBH in Q4 2021 and has held it in 12 quarters since. 7 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

  • CoreCap Advisors held 190 shares of VanEck Biotech ETF worth $38.6K as of Q2 2026.
  • CoreCap Advisors left its VanEck Biotech ETF share count unchanged in Q2 2026.
  • VanEck Biotech ETF made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1515 holding.
  • CoreCap Advisors first reported a position in VanEck Biotech ETF in Q4 2021 and has held it in 12 quarters since.
  • 7 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.